The imPAct of Trimetazidine on MicrOcirculation after Stenting for stable coronary artery disease (PATMOS study)

BACKGROUND: Myocardial ischemia is caused by epicardial coronary artery stenosis or atherosclerotic disease affecting microcirculation. Trimetazidine (TMZ), promotes glucose oxidation which optimizes cellular energy processes in ischemic conditions. Small studies demonstrated protective effects of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilic, Ivan, Timcic, Stefan, Milosevic, Maja, Boskovic, Srdjan, Odanovic, Natalija, Furtula, Matija, Dobric, Milan, Aleksandric, Srdjan, Otasevic, Petar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348888/
https://www.ncbi.nlm.nih.gov/pubmed/37456821
http://dx.doi.org/10.3389/fcvm.2023.1112198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348888/
https://www.ncbi.nlm.nih.gov/pubmed/37456821
http://dx.doi.org/10.3389/fcvm.2023.1112198

Ejemplares similares